Compugen has hired Noam Shani as vice president of biology research and development, where he will oversee the Israeli company’s drug research and development, and manage therapeutic protein candidate discovery, selection, validation, and preclinical and clinical development. Shani joins Compugen from Medgenics, where he was vice president of research and development.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.